ES2062011T3 - Derivado de ciclohexano. - Google Patents

Derivado de ciclohexano.

Info

Publication number
ES2062011T3
ES2062011T3 ES89308062T ES89308062T ES2062011T3 ES 2062011 T3 ES2062011 T3 ES 2062011T3 ES 89308062 T ES89308062 T ES 89308062T ES 89308062 T ES89308062 T ES 89308062T ES 2062011 T3 ES2062011 T3 ES 2062011T3
Authority
ES
Spain
Prior art keywords
hetero
cycle
formula
derivative
carbamoyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89308062T
Other languages
English (en)
Inventor
Teruo Oku
Chiyoshi Kasahara
Takehiko Ohkawa
Masashi Hashimoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB888819257A external-priority patent/GB8819257D0/en
Priority claimed from GB898908005A external-priority patent/GB8908005D0/en
Priority claimed from GB898909794A external-priority patent/GB8909794D0/en
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2062011T3 publication Critical patent/ES2062011T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22—Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/34—Compounds containing oxirane rings with hydrocarbon radicals, substituted by sulphur, selenium or tellurium atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

UN DERIVADO DE CICLOHEXANO DE FORMULA (I), DONDE R1 ES HALOMETILO, O ARILTIOMETILO QUE PUEDE TENER AMINO, ALCOXI INFERIOR O ACILAMINO; R2 ES ALCOXI INFERIOR; R3 ES COMPUESTO DE FORMULA: (FIG. A) O (FIG. B); Y R4 ES H, ALQUILCARBAMOILO INFERIOR, ALQUILCARBAMOILOXI INFERIOR ALQUILCARBAMOILO, CARBONILO HETEROCICLICO O CARBAMOILO HETEROCICLICO O SUS SALES. TAMBIEN SE DESCRIBE UN PROCEDIMIENTO PARA OBTENER EL DERIVADO DE CICLOHEXANO, JUNTO CON UNA COMPOSICION FARMACEUTICA QUE TIENE EL MISMO COMO INGREDIENTE ACTIVO. LOS COMPUESTOS TIENEN ACTIVIDAD INHIBIDORA DE ANGIOGENESIS Y ADEMAS SON UTILES EN EL TRATAMIENTO DE, POR EJEMPLO, TUMORES, ARTRITIS REUMATICA, RETINOPATIA DIABETICA Y SORIASIS.
ES89308062T 1988-08-12 1989-08-08 Derivado de ciclohexano. Expired - Lifetime ES2062011T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB888819257A GB8819257D0 (en) 1988-08-12 1988-08-12 Cyclohexane derivative
GB898908005A GB8908005D0 (en) 1989-04-10 1989-04-10 Cyclohexane derivative
GB898909794A GB8909794D0 (en) 1989-04-28 1989-04-28 Cyclohexane derivative

Publications (1)

Publication Number Publication Date
ES2062011T3 true ES2062011T3 (es) 1994-12-16

Family

ID=27264023

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89308062T Expired - Lifetime ES2062011T3 (es) 1988-08-12 1989-08-08 Derivado de ciclohexano.

Country Status (9)

Country Link
US (1) US4954496A (es)
EP (1) EP0354767B1 (es)
JP (1) JP2811783B2 (es)
KR (1) KR0130766B1 (es)
CA (1) CA1316921C (es)
DE (1) DE68911417T2 (es)
ES (1) ES2062011T3 (es)
HU (1) HU203543B (es)
IE (1) IE63045B1 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5164410A (en) * 1988-01-09 1992-11-17 Takeda Chemical Industries, Ltd. Fumagillol derivatives and pharmaceutical compositions thereof
ATE150750T1 (de) * 1988-09-01 1997-04-15 Takeda Chemical Industries Ltd Fumagillol-derivate
US5180738A (en) * 1988-09-01 1993-01-19 Takeda Chemical Industries Fumagillol derivatives and pharmaceutical compositions thereof
US5166172A (en) * 1988-09-01 1992-11-24 Takeda Chemical Industries, Ltd. Fumagillol derivatives and pharmaceutical compositions thereof
US5290807A (en) * 1989-08-10 1994-03-01 Children's Medical Center Corporation Method for regressing angiogenesis using o-substituted fumagillol derivatives
US6017954A (en) * 1989-08-10 2000-01-25 Children's Medical Center Corp. Method of treating tumors using O-substituted fumagillol derivatives
EP0415294A3 (en) * 1989-08-31 1991-06-12 Takeda Chemical Industries, Ltd. Cyclohexanol derivatives, production and use thereof
TW282399B (es) * 1990-05-25 1996-08-01 Takeda Pharm Industry Co Ltd
DE69231457T2 (de) * 1991-06-21 2001-05-23 Takeda Chemical Industries Ltd Zyklodextrin-Zusammensetzung enthaltend Fumagillol-Derivate
ATE153854T1 (de) * 1992-12-16 1997-06-15 Takeda Chemical Industries Ltd Stabile pharmazeutische zubereitung mit fumagillolderivaten
US5710148A (en) * 1995-03-06 1998-01-20 Senju Pharmaceuticals Co., Ltd. Corneal opacification inhibitory composition
FR2733499B1 (fr) * 1995-04-27 1997-05-30 Adir Nouvelles tetrahydropyrano(3,2-d)oxazolones substituees, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2733498B1 (fr) * 1995-04-27 1997-05-30 Adir Nouveaux composes cyclohexaniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
WO1997032868A1 (en) * 1996-03-06 1997-09-12 Tsumura & Co. Novel iridoid derivatives and neovascularization inhibitors containing the same as active ingredient
US6225478B1 (en) 1997-03-05 2001-05-01 Tsumura & Co. Iridoid derivatives and neovascularization inhibitors containing the same as active ingredient
US6548477B1 (en) 2000-11-01 2003-04-15 Praecis Pharmaceuticals Inc. Therapeutic agents and methods of use thereof for the modulation of angiogenesis
US7105482B2 (en) 2000-11-01 2006-09-12 Praecis Pharmaceuticals, Inc. Methionine aminopeptidase-2 inhibitors and methods of use thereof
US6919307B2 (en) 2000-11-01 2005-07-19 Praecis Pharmaceuticals, Inc. Therapeutic agents and methods of use thereof for the modulation of angiogenesis
EP1330447A2 (en) * 2000-11-01 2003-07-30 Praecis Pharmaceuticals Incorporated Peptides as met-ap2 inhibitors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2500016A (en) * 1947-04-26 1950-03-07 Canadian Ind Epoxyethylcyclohexane hydroxy ethers

Also Published As

Publication number Publication date
KR0130766B1 (ko) 1998-04-09
DE68911417D1 (de) 1994-01-27
EP0354767B1 (en) 1993-12-15
HUT51265A (en) 1990-04-28
KR900003163A (ko) 1990-03-23
IE892506L (en) 1990-02-12
HU203543B (en) 1991-08-28
IE63045B1 (en) 1995-03-22
JPH0276866A (ja) 1990-03-16
EP0354767A1 (en) 1990-02-14
JP2811783B2 (ja) 1998-10-15
DE68911417T2 (de) 1994-04-14
US4954496A (en) 1990-09-04
CA1316921C (en) 1993-04-27

Similar Documents

Publication Publication Date Title
ES2062011T3 (es) Derivado de ciclohexano.
ES2067546T3 (es) Derivado de oxaspiro(2,5)octano.
ATE495793T1 (de) Antitumorzusammensetzungen welche ecteinascidin 743 enthalten
ES2078905T3 (es) Nuevos compuestos heterociclicos condensados y su utilizacion para medicamentos.
ES2175161T3 (es) Derivados de piperazina como antagonistas de taquiquinina.
MX9303158A (es) Derivados de aminoquinolona substituidos con grupoarilo o con un grupo heterociclico aromatico; y agente anti-vih.
PT97689A (pt) Processo para a preparacao de composicoes farmaceuticas incorporando como ingrediente activo isoxazol-4-carboxilamida e hidroxialquilideno-cianoacetamida
NZ501276A (en) 4-bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as MEK inhibitors in treating proliferative disorders
NO308794B1 (no) Farmakologisk aktive pyridin-derivater, preparater inneholdende forbindelsene samt forbindelsenes anvendelse
DK0583421T3 (da) Substituerede dibenzoxazepinforbindelser, lægemidler og fremgangsmåder til anvendelse
FI952734A0 (fi) 2-Amino-6-A-propyyli-amino-4,5,6,7-tetrahydrobentsotiatsolin (Pramipexolin) käyttö lääkeaineena, jolla on antidepressiivinen vaikutus
ES2051753T3 (es) N-(1-azabiciclo(2.2.2)octo-3-il) benzamidas y tiobenzamidas ansioliticas.
AR007088A1 (es) 2,4-diaminopirimidinas sustituidas, compuestos intermedios utilizados en su preparacion, procedimiento para la preparacion de dichas 2,4-diaminopirimidinas sustituidas, medicamentos que las contienen y empleos de dichas pirimidinas
ES2130152T3 (es) Medicamentos para tratar dolencias inflamatorias o para analgesia que contienen un nsaid y ranitidina/citrato de bismuto.
ES2038359T3 (es) Procedimiento para la obtencion de formulaciones inyectables intramusculares de inhibidores de girasa.
ES2135342B1 (es) Uso del raloxifeno o una sal o salvato del mismo en la preparacion de un medicamento para prevenir el cancer de mama.
ES2091183T3 (es) Metodo para mejorar el sueño.
ES2083972T3 (es) Arilalquil-aminas y -amidas con propiedades anticonvulsivas y neuroprotectoras.
ES2125354T3 (es) Composicion a base de tandospirona o de sus analogos.
ES2043943T3 (es) Procedimiento para la preparacion de compuestos con actividad analgesica central.
AR026242A1 (es) Empleo de 2-amino-3,4-dihidro-quinazolinas para la preparacion de un medicamento para el tratamiento o profilaxis de enfermedades provocadas por estadosisquemicos
ES2065855B1 (es) Procedimiento para la preparacion de nuevos derivados desoxiazafosfolipidicos con accion inhibidora de la fosfolipasa a2, nuevos derivados desoxiazafosfolipidicos obtenidos y utilizacion de los mismos.
MX9203068A (es) Compuestos activirales oralmente activos.
ES408605A1 (es) Procedimiento para preparar oxazoles 2,4,5-trisustituidos.
AR026241A1 (es) Empleo de carbinoles 2-imidazolil substituidos para la preparacion de un medicamento para el tratamiento o profilaxis de enfermedades provocadas porestados isquemicos

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 354767

Country of ref document: ES